Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
95688293 | 9568829 | 3 | F | 201212 | 20160728 | 20130930 | 20160803 | EXP | US-AMGEN-USASP2013047701 | AMGEN | 68.00 | YR | E | F | Y | 63.49000 | KG | 20160803 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
95688293 | 9568829 | 1 | PS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 50 MG EVERY OTHER WEEK | 103795 | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | QOW | ||||||||
95688293 | 9568829 | 2 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 50 MG, QWK | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | ||||||
95688293 | 9568829 | 3 | C | METHOTREXATE. | METHOTREXATE | 1 | 2.5 MG, UNK | 0 | 2.5 | MG | TABLET | ||||||||
95688293 | 9568829 | 4 | C | TRAMADOL. | TRAMADOL | 1 | 50 MG, UNK | 0 | 50 | MG | TABLET | ||||||||
95688293 | 9568829 | 5 | C | FOLIC ACID. | FOLIC ACID | 1 | 1 MG, UNK | 0 | 1 | MG | TABLET | ||||||||
95688293 | 9568829 | 6 | C | VITAMIN B COMPLEX WITH C | ASCORBIC ACIDCALCIUM PANTOTHENATECYANOCOBALAMINNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVINTHIAMINE MONONITRATE | 1 | UNK | 0 | TABLET | ||||||||||
95688293 | 9568829 | 7 | C | RECLAST | ZOLEDRONIC ACID | 1 | 5/100 ML | 0 | INJECTION |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
95688293 | 9568829 | 1 | Rheumatoid arthritis |
95688293 | 9568829 | 2 | Arthropathy |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
95688293 | 9568829 | HO |
95688293 | 9568829 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
95688293 | 9568829 | Blister rupture | |
95688293 | 9568829 | Bronchitis | |
95688293 | 9568829 | Chills | |
95688293 | 9568829 | Colonoscopy | |
95688293 | 9568829 | Decreased appetite | |
95688293 | 9568829 | Drug effect decreased | |
95688293 | 9568829 | Endoscopy | |
95688293 | 9568829 | Injection site bruising | |
95688293 | 9568829 | Injection site rash | |
95688293 | 9568829 | Injection site vesicles | |
95688293 | 9568829 | Insomnia | |
95688293 | 9568829 | Night sweats | |
95688293 | 9568829 | Pneumonia | |
95688293 | 9568829 | Rheumatoid arthritis | |
95688293 | 9568829 | Thermal burn | |
95688293 | 9568829 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
95688293 | 9568829 | 1 | 2008 | 201303 | 0 | |
95688293 | 9568829 | 2 | 2016 | 0 |